Literature DB >> 9769120

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line.

E Abril1, L M Real, A Serrano, P Jimenez, A García, J Canton, I Trigo, F Garrido, F Ruiz-Cabello.   

Abstract

HC class I expression can be up-regulated by interferons (IFN) and other cytokines. Both IFNalpha and IFNgamma have been shown to exert their effects via a recently discovered signalling pathway by inducing tyrosine phosphorylation of their receptors. Receptors for interferons and other cytokines signal through the action of associated protein tyrosine kinases of the JAK family (Janus kinase) and latent cytoplasmic transcriptional activators from the STAT family (signal transducers and activators of transcription). Here we report a gastric adenocarcinoma cell line, AGS, that is defective in its response to either IFNalpha or IFNgamma. AGS cells display selective alterations only in MHC class I inducibility and not in constitutive MHC class I expression. In nuclear extracts of AGS cells, no binding activity to interferon-responsive elements (GAS/ISRE) was observed. We found that AGS cells showed an extremely low level of STAT1 expression, which may be responsible for the absence of biological response to IFN. Because STAT1-deficient cells are highly sensitive to infection by virus, the absence of these proteins may also contribute to the tumor phenotype, giving the tumor a selective advantage, by inhibiting cell growth suppression mediated by IFN and abetting escape from the T cell antitumor response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769120     DOI: 10.1007/s002620050511

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  18 in total

1.  Morphology and infectivity of virus that persistently caused infection in an AGS cell line.

Authors:  Yukimasa Ooi; Eriko Daikoku; Hong Wu; Hiroaki Aoki; Chizuko Morita; Takashi Nakano; Takehiro Kohno; Tomohiko Takasaki; Kouichi Sano
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

2.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

Authors:  C V Ramana; N Grammatikakis; M Chernov; H Nguyen; K C Goh; B R Williams; G R Stark
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppression.

Authors:  Jinbo Gao; Yujun Wang; Quanhua Xing; Jin Yan; Maheswari Senthil; Yasir Akmal; Claudia M Kowolik; Julia Kang; David M Lu; Ming Zhao; Zhixiu Lin; Christopher H K Cheng; M L Richard Yip; John H Yim
Journal:  Mol Cancer Ther       Date:  2011-08-04       Impact factor: 6.261

4.  Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells.

Authors:  A R Karpf; P W Peterson; J T Rawlins; B K Dalley; Q Yang; H Albertsen; D A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

Authors:  T Rodríguez; R Méndez; A Del Campo; N Aptsiauri; J Martín; G Orozco; G Pawelec; D Schadendorf; F Ruiz-Cabello; F Garrido
Journal:  Immunogenetics       Date:  2006-12-20       Impact factor: 2.846

6.  IFN-β Selectively Inhibits IL-2 Production through CREM-Mediated Chromatin Remodeling.

Authors:  Dennis C Otero; Nancy J Fares-Frederickson; Menghong Xiao; Darren P Baker; Michael David
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

Review 7.  MHC heterogeneity and response of metastases to immunotherapy.

Authors:  Ignacio Algarra; Federico Garrido; Angel M Garcia-Lora
Journal:  Cancer Metastasis Rev       Date:  2021-04-15       Impact factor: 9.264

8.  Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.

Authors:  Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis M Real; Federico Garrido; Teresa Cabrera
Journal:  Immunogenetics       Date:  2008-06-11       Impact factor: 2.846

Review 9.  Cancer immune escape: MHC expression in primary tumours versus metastases.

Authors:  Federico Garrido; Natalia Aptsiauri
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

10.  IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells.

Authors:  J Gao; M Senthil; B Ren; J Yan; Q Xing; J Yu; L Zhang; J H Yim
Journal:  Cell Death Differ       Date:  2009-10-23       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.